09 630 1961


John R&D
Professor John Ormiston
Medical Director
Mercy Angiography has been actively involved in research for over 20 years, producing internationally recognised cardiac research and development.

The research and development projects vary from clinical trials and registries of new cardiac devices to bench testing of new devices.

Clinical trials and registries mainly investigate the efficacy and safety of various novel stent designs in the treatment of narrowings of the coronary arteries. 
Mercy Angiography -Fay Sommerville
Fay Sommerville
Clinical Research Coordinator
Mercy Angiography was the first facility in Asia Pacific to conduct a Transcatheter Aortic Valve Implantation (TAVI) procedure and the first facility in world to implant many new stents including fully desolvable stents that do their job then go away. 

Clinical trials have different inclusion and exclusion criteria and based upon these you may be invited to participate in a study by your doctor or our clinical research coordinators. All our research projects offer excellent follow up over a number of years. Involvement in studies is optional and may not directly benefit a patient. However, extremely valuable information can be gained from the participation that will benefit others in future.
Mercy Angiography -Jane Liggins-03(copy)
Jane Liggins
Part-time Clinical Research Coordinator
Bruce R&DBruce Webber
Clinical Research Coordinator
Professor Ormiston and the staff of Mercy Angiography are also world renowned for bench testing of stents. Many international medical device companies send stents to Mercy Angiography for testing.

These tests are important in the development of improved stent designs and techniques. Through leading edge research, Mercy Angiography is able to offer the latest stents and techniques to patients.

All research involving patients in Mercy Angiography has full approval from the New Zealand Health and Disability Ethics Committee.